Cidara Therapeutics Announces Pricing of Initial Public Offering
April 15, 2015 07:30 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, April 15, 2015 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other...
VaxInnate Receives Extension of Contract from BARDA for Development of Seasonal and Pandemic Influenza Vaccines
February 17, 2015 08:00 ET
|
VaxInnate Corporation
Cranbury, NJ, Feb. 17, 2015 (GLOBE NEWSWIRE) -- VaxInnate Corporation, a biotechnology firm pioneering a
breakthrough vaccine technology, today announced that it has
executed a contract modification...
VaxInnate Initiates Phase 1b/2 Clinical Trial of Quadrivalent Seasonal Influenza Vaccine Candidate, VAX2012Q, in Elderly
December 08, 2014 08:00 ET
|
VaxInnate Corporation
Cranbury, NJ, Dec. 8, 2014 (GLOBE NEWSWIRE) -- VaxInnate Corporation, a biotechnology firm pioneering a
breakthrough vaccine technology platform, today announced the
initiation of a double-blind,...
Point-of-Care Technologies Will Transform Customer Markets in the Next Decade
March 06, 2014 07:30 ET
|
Lux Research
BOSTON, MA--(Marketwired - Mar 6, 2014) - Fueled by point-of-care (POC) technologies, the health care industry is headed for transformative change toward a patient-centric model. The near-term...
Fedora Pharmaceuticals Demonstrates that FPI-1465 Increases Activity of Certain Antibiotics against Drug-Resistant Bacteria
September 12, 2013 13:00 ET
|
Fedora Pharmaceuticals, Inc.
EDMONTON, Alberta, Sept. 12, 2013 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc. and its collaborators presented
results of preclinical studies demonstrating that FPI-1465 increases
the activity of...
Tune in to Genesis Global Radio This Week to Hear Guests Paula Webster-Grant, Rhonda Knutson, Patricia Fayerweather-Harlow, Kimberly Berg, Joanne Charette, Dr. Carlos Guerra, M.J. Domet, and Dr. Barbara Morrison
April 08, 2013 16:10 ET
|
Genesis Global Media, Inc.
NEW YORK, NY, April 8, 2013 (GLOBE NEWSWIRE) -- This Week, tune in to hear our guests share their expertise on
music production, life coaching, self-empowerment, advances in
infectious disease, the...
Battelle Wins $102M NIAID Biodefense Research Contract
July 18, 2012 10:30 ET
|
Battelle
COLUMBUS, OH--(Marketwire - Jul 18, 2012) - Battelle has won a single-source award from the U.S. Department of Health and Human Services' National Institutes of Health for evaluation and testing...
Stellar Biotechnologies Announces Biotech Showcase 2012 Presentations
January 04, 2012 09:10 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Jan 4, 2012) - Stellar Biotechnologies, Inc. ("Stellar") (TSX VENTURE: KLH) (PINKSHEETS: SBOTF) is pleased to announce that it will be making two presentations at...
ContraFect CEO Robert Nowinski Announces Agreement With The Rockefeller University to Commercialize Eight Patents Covering Bacterial Treatments
November 18, 2010 09:12 ET
|
ContraFect Corporation
NEW YORK, NY--(Marketwire - November 18, 2010) - ContraFect Corporation, the company that is pioneering the use of recombinant proteins for the treatment of drug resistant bacteria, announced that it...
MIT Enterprise Forum of Cambridge Presents "Vaccines and Global Health: New Technologies Create Global Opportunities"
November 04, 2009 15:40 ET
|
MIT Enterprise Forum of Cambridge
CAMBRIDGE, MA--(Marketwire - November 4, 2009) - On November 9, the MIT Enterprise Forum of
Cambridge will present a session on the development of new technologies
for the research, development and...